Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis
- PMID: 8896570
- DOI: 10.1038/ng1196-348
Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis
Abstract
The GM2 gangliosidoses, Tay-Sachs and Sandhoff diseases, are caused by mutations in the HEXA (alpha-subunit) and HEXB (beta-subunit) genes, respectively. Each gene encodes a subunit for the heterodimeric lysosomal enzyme, beta-hexosaminidase A (alpha beta), as well as for the homodimers beta-hexosaminidase B (beta beta) and S (alpha alpha). In this study, we have produced mice that have both Hexa and Hexb genes disrupted through interbreeding Tay-Sachs (Hexa-/-) and Sandhoff (Hexb-/-) disease model mice. Lacking both the alpha and beta-subunits these 'double knockout' mice displayed a total deficiency of all forms of lysosomal beta-hexosaminidase including the small amount of beta-hexosaminidase S present in the Sandhoff disease model mice. More surprisingly, these mice showed the phenotypic, pathologic and biochemical features of the mucopolysaccharidoses, lysosomal storage diseases caused by the accumulation of glycosaminoglycans. The mucopolysaccharidosis phenotype is not seen in the Tay-Sachs or Sandhoff disease model mice or in the corresponding human patients. This result demonstrates that glycosaminoglycans are crucial substrates for beta-hexosaminidase and that their lack of storage in Tay-Sachs and Sandhoff diseases is due to functional redundancy in the beta-hexosaminidase enzyme system.
Similar articles
-
Mice deficient in all forms of lysosomal beta-hexosaminidase show mucopolysaccharidosis-like pathology.J Neuropathol Exp Neurol. 1997 Jun;56(6):693-703. J Neuropathol Exp Neurol. 1997. PMID: 9184660
-
Structure and expression of the mouse beta-hexosaminidase genes, Hexa and Hexb.Genomics. 1994 Jun;21(3):588-96. doi: 10.1006/geno.1994.1318. Genomics. 1994. PMID: 7959736
-
Promoters for the human beta-hexosaminidase genes, HEXA and HEXB.DNA Cell Biol. 1996 Feb;15(2):89-97. doi: 10.1089/dna.1996.15.89. DNA Cell Biol. 1996. PMID: 8634145
-
[Recent advances in molecular genetics of GM2 gangliosidosis].Nihon Rinsho. 1995 Dec;53(12):2988-93. Nihon Rinsho. 1995. PMID: 8577047 Review. Japanese.
-
[Molecular pathogenesis and therapeutic approach of GM2 gangliosidosis].Yakugaku Zasshi. 2013;133(2):269-74. doi: 10.1248/yakushi.12-00199. Yakugaku Zasshi. 2013. PMID: 23370522 Review. Japanese.
Cited by
-
Enhancement of neuromuscular dynamics and strength behavior using extremely low magnitude mechanical signals in mice.J Biomech. 2014 Jan 3;47(1):162-7. doi: 10.1016/j.jbiomech.2013.09.024. Epub 2013 Oct 9. J Biomech. 2014. PMID: 24157062 Free PMC article.
-
Mouse model of GM2 activator deficiency manifests cerebellar pathology and motor impairment.Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8138-43. doi: 10.1073/pnas.94.15.8138. Proc Natl Acad Sci U S A. 1997. PMID: 9223328 Free PMC article.
-
Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice.J Clin Invest. 1998 May 1;101(9):1881-8. doi: 10.1172/JCI2127. J Clin Invest. 1998. PMID: 9576752 Free PMC article.
-
Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model.J Clin Invest. 2016 May 2;126(5):1691-703. doi: 10.1172/JCI85300. Epub 2016 Mar 28. J Clin Invest. 2016. PMID: 27018595 Free PMC article.
-
Quantitative measurement of postural sway in mouse models of human neurodegenerative disease.Neuroscience. 2007 Sep 21;148(4):825-32. doi: 10.1016/j.neuroscience.2007.07.025. Epub 2007 Jul 21. Neuroscience. 2007. PMID: 17764851 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous